Narcolepsy Market Report 2026
Narcolepsy Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Narcolepsy Market Report 2026

Global Outlook – By Type (Type 1, Type 2), By Treatment (Antidepressants, Stimulants, Sodium Oxybate, Other Treatments), By Diagnosis (Polysomnogram, Multiple Sleep Latency Test) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Narcolepsy Market Overview

• Narcolepsy market size has reached to $3.95 billion in 2025

• Expected to grow to $6.62 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%

• Growth Driver: Obesity Fueling Narcolepsy Market Growth

• Market Trend: Development Of Extended-Release Medications In The Narcolepsy Market

North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Narcolepsy Market?

Narcolepsy is a chronic neurological disorder that affects the brain's ability to regulate sleep-wake cycles. People with narcolepsy often experience excessive daytime sleepiness and uncontrollable episodes of falling asleep during the day, which can occur during any type of activity. Narcolepsy is frequently accompanied by cataplexy, a sudden loss of muscle tone triggered by strong emotions.

The main types of narcolepsy are type 1 and type 2. Type 1 narcolepsy, also known as NT1, is characterized by excessive daytime sleepiness and cataplexy, which is a sudden loss of muscle tone often triggered by strong emotions. The treatment of narcolepsy includes antidepressants, stimulants, sodium oxybate, and others, and it is diagnosed by a polysomnogram and multiple sleep latency tests. The various end users include hospitals, retail pharmacies, and others.

Narcolepsy Market Global Report 2026 Market Report bar graph

What Is The Narcolepsy Market Size and Share 2026?

The narcolepsy market size has grown rapidly in recent years. It will grow from $3.95 billion in 2025 to $4.38 billion in 2026 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to limited awareness of narcolepsy, delayed diagnosis rates, reliance on stimulant medications, introduction of sodium oxybate, growth in sleep disorder research.

What Is The Narcolepsy Market Growth Forecast?

The narcolepsy market size is expected to see rapid growth in the next few years. It will grow to $6.62 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to rising prevalence of sleep disorders, increasing r&d investment, expanding non-stimulant therapeutic pipeline, growing patient education initiatives, advancements in precision medicine approaches. Major trends in the forecast period include rising awareness and diagnosis of narcolepsy, increasing adoption of combination therapy, growing demand for long-acting therapeutics, expansion of non-stimulant treatment options, enhanced focus on cataplexy-specific therapeutics.

Customer representative image Book your 30 minutes free consultation with our research experts

Global Narcolepsy Market Segmentation

1) By Type: Type 1, Type 2

2) By Treatment: Antidepressants, Stimulants, Sodium Oxybate, Other Treatments

3) By Diagnosis: Polysomnogram, Multiple Sleep Latency Test

Subsegments:

1) By Type 1: Stimulant Medications, Antidepressants, Sodium Oxybate, Immunosuppressive Treatments

2) By Type 2: Stimulant Medications, Sodium Oxybate, Antidepressants

What Is The Driver Of The Narcolepsy Market?

The growing number of obese people is expected to propel the growth of the narcolepsy market going forward. Obesity is a medical condition characterized by an excessive accumulation of body fat, which poses a health risk. The number of obese people is rising due to increasingly sedentary lifestyles, poor dietary habits, and environmental factors that promote calorie-dense food consumption and reduce physical activity. Obesity can contribute to narcolepsy by disrupting metabolic and hormonal balances, potentially leading to changes in sleep patterns and the regulation of wakefulness. For instance, in May 2025, according to the Office for Health Improvement & Disparities, a UK-based government department, an estimated 64.5 percent of adults aged 18 and over in England were overweight or living with obesity in 2023–2024, up from 64.0 percent in 2022–2023, reflecting a continuing upward trend. Therefore, the growing number of obese people is driving the growth of the narcolepsy industry.

Key Players In The Global Narcolepsy Market

Major companies operating in the narcolepsy market are Pfizer Inc., Merck & Co. Inc, Novartis AG, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries, Otsuka Pharmaceutical, Sumitomo Pharma Company Limited, Jazz Pharmaceuticals, Alkermes, Harmony Biosciences, Cerevel Therapeutics, Axsome Therapeutics Inc., Avadel Pharmaceuticals, NLS Pharmaceutics AG, KemPharm, Bioprojet Pharma, Centessa Pharmaceuticals, Hikma Pharmaceuticals, Theranexus SA, Eisai Co Ltd, Ligand Pharmaceuticals, Graymark Healthcare Inc, H Lundbeck A/S

Global Narcolepsy Market Trends and Insights

Major companies operating in the narcolepsy market are increasing their focus on developing novel medications, such as extended-release sodium oxybate, to address the growing demand for effective treatments. Extended-release sodium oxybate is a medication used in the treatment of narcolepsy. The extended-release formulation allows for controlled release of the medication over a longer period, providing sustained symptom relief throughout the night and improving sleep quality for individuals with narcolepsy. For instance, in June 2023, Avadel Pharmaceuticals plc, an Ireland-based pharmaceutical company, launched LUMRYZ in the United States. LUMRYZ is an extended-release formulation of sodium oxybate approved by the FDA for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. It is the first and only once-at-bedtime oxybate treatment for narcolepsy, offering a significant improvement over twice-nightly oxybate products by avoiding the need to wake up for a second dose at night.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Narcolepsy Market?

In December 2023, NLS Pharmaceutics AG, a Switzerland-based pharmaceutical company, acquired a dual orexin receptor agonist platform from Aexon Labs Inc. for an undisclosed amount. The acquisition grants NLS Pharmaceutics the option to in-license all of Aexon Labs' assets for the treatment of narcolepsy and other neurodegenerative disorders, as well as global rights to multiple highly selective orexin-1/orexin-2 receptor agonists. Aexon Labs Inc. is a US-based company involved in the development of treatments for narcolepsy and neurodegenerative disease.

Regional Outlook

North America was the largest region in the narcolepsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Narcolepsy Market?

The narcolepsy market consists of revenues earned by entities by providing services such as cognitive behavioral therapy, telemedicine consultations, lifestyle management programs, and patient education programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The narcolepsy market also includes sales of dietary supplements, Pitolisant, Modafinil, and Armodafinil. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Narcolepsy Market Report 2026?

The narcolepsy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the narcolepsy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Narcolepsy Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $4.38 billion
Revenue Forecast In 2035 $6.62 billion
Growth Rate CAGR of 10.8% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Treatment, Diagnosis
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., Merck & Co. Inc, Novartis AG, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries, Otsuka Pharmaceutical, Sumitomo Pharma Company Limited, Jazz Pharmaceuticals, Alkermes, Harmony Biosciences, Cerevel Therapeutics, Axsome Therapeutics Inc., Avadel Pharmaceuticals, NLS Pharmaceutics AG, KemPharm, Bioprojet Pharma, Centessa Pharmaceuticals, Hikma Pharmaceuticals, Theranexus SA, Eisai Co Ltd, Ligand Pharmaceuticals, Graymark Healthcare Inc, H Lundbeck A/S
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Narcolepsy Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Narcolepsy Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Narcolepsy Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Narcolepsy Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Awareness And Diagnosis Of Narcolepsy

4.2.2 Increasing Adoption Of Combination Therapy

4.2.3 Growing Demand For Long-Acting Therapeutics

4.2.4 Expansion Of Non-Stimulant Treatment Options

4.2.5 Enhanced Focus On Cataplexy-Specific Therapeutics

5. Narcolepsy Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Retail Pharmacies

5.3 Specialty Neurology Clinics

5.4 Sleep Disorder Centers

5.5 Research & Academic Institutions

6. Narcolepsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Narcolepsy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Narcolepsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Narcolepsy Market Size, Comparisons And Growth Rate Analysis

7.3. Global Narcolepsy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Narcolepsy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Narcolepsy Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Narcolepsy Market Segmentation

9.1. Global Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Type 1, Type 2

9.2. Global Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antidepressants, Stimulants, Sodium Oxybate, Other Treatments

9.3. Global Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Polysomnogram, Multiple Sleep Latency Test

9.4. Global Narcolepsy Market, Sub-Segmentation Of Type 1, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Stimulant Medications, Antidepressants, Sodium Oxybate, Immunosuppressive Treatments

9.5. Global Narcolepsy Market, Sub-Segmentation Of Type 2, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Stimulant Medications, Sodium Oxybate, Antidepressants

10. Narcolepsy Market Regional And Country Analysis

10.1. Global Narcolepsy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Narcolepsy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Narcolepsy Market

11.1. Asia-Pacific Narcolepsy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Narcolepsy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Narcolepsy Market

12.1. China Narcolepsy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Narcolepsy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Narcolepsy Market

13.1. India Narcolepsy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Narcolepsy Market

14.1. Japan Narcolepsy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Narcolepsy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Narcolepsy Market

15.1. Australia Narcolepsy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Narcolepsy Market

16.1. Indonesia Narcolepsy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Narcolepsy Market

17.1. South Korea Narcolepsy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Narcolepsy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Narcolepsy Market

18.1. Taiwan Narcolepsy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Narcolepsy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Narcolepsy Market

19.1. South East Asia Narcolepsy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Narcolepsy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Narcolepsy Market

20.1. Western Europe Narcolepsy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Narcolepsy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Narcolepsy Market

21.1. UK Narcolepsy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Narcolepsy Market

22.1. Germany Narcolepsy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Narcolepsy Market

23.1. France Narcolepsy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Narcolepsy Market

24.1. Italy Narcolepsy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Narcolepsy Market

25.1. Spain Narcolepsy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Narcolepsy Market

26.1. Eastern Europe Narcolepsy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Narcolepsy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Narcolepsy Market

27.1. Russia Narcolepsy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Narcolepsy Market

28.1. North America Narcolepsy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Narcolepsy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Narcolepsy Market

29.1. USA Narcolepsy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Narcolepsy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Narcolepsy Market

30.1. Canada Narcolepsy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Narcolepsy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Narcolepsy Market

31.1. South America Narcolepsy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Narcolepsy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Narcolepsy Market

32.1. Brazil Narcolepsy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Narcolepsy Market

33.1. Middle East Narcolepsy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Narcolepsy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Narcolepsy Market

34.1. Africa Narcolepsy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Narcolepsy Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Narcolepsy Market Regulatory and Investment Landscape

36. Narcolepsy Market Competitive Landscape And Company Profiles

36.1. Narcolepsy Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Narcolepsy Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Narcolepsy Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck & Co. Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Teva Pharmaceutical Industries Overview, Products and Services, Strategy and Financial Analysis

37. Narcolepsy Market Other Major And Innovative Companies

Otsuka Pharmaceutical, Sumitomo Pharma Company Limited, Jazz Pharmaceuticals, Alkermes, Harmony Biosciences, Cerevel Therapeutics, Axsome Therapeutics Inc., Avadel Pharmaceuticals, NLS Pharmaceutics AG, KemPharm, Bioprojet Pharma, Centessa Pharmaceuticals, Hikma Pharmaceuticals, Theranexus SA, Eisai Co Ltd

38. Global Narcolepsy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Narcolepsy Market

40. Narcolepsy Market High Potential Countries, Segments and Strategies

40.1 Narcolepsy Market In 2030 - Countries Offering Most New Opportunities

40.2 Narcolepsy Market In 2030 - Segments Offering Most New Opportunities

40.3 Narcolepsy Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Narcolepsy Market, Overview Of Key Products - Product Examples
  • Table 2: Global Narcolepsy Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Narcolepsy Market, Supply Chain Analysis
  • Table 4: Global Narcolepsy Market, Major Raw Material Providers
  • Table 5: Global Narcolepsy Market, Major Resource Providers
  • Table 6: Global Narcolepsy Market, Major Manufacturers (Suppliers)
  • Table 7: Global Narcolepsy Market, Major Distributors And Channel Partners
  • Table 8: Global Narcolepsy Market, Key Technologies & Future Trends
  • Table 9: Global Narcolepsy Market, Major Trends
  • Table 10: Global Narcolepsy Market, Major End Users
  • Table 11: Global Narcolepsy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Narcolepsy Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Narcolepsy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Narcolepsy Market - TAM, US$ Billion, 2025
  • Table 15: Global Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Narcolepsy Market, Sub-Segmentation Of Type 1, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Narcolepsy Market, Sub-Segmentation Of Type 2, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Narcolepsy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Narcolepsy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Indonesia, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: South Korea, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Taiwan, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South East Asia, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Western Europe, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: UK, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Germany, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: France, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Italy, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Spain, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Eastern Europe, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Russia, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: North America, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: USA, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Canada, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: South America, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Brazil, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Middle East, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Africa, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Global Narcolepsy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 95: Global Narcolepsy Market - Company Scoring Matrix
  • Table 96: Pfizer Inc. Financial Performance
  • Table 97: Merck & Co. Inc Financial Performance
  • Table 98: Novartis AG Financial Performance
  • Table 99: Takeda Pharmaceutical Company Limited Financial Performance
  • Table 100: Teva Pharmaceutical Industries Financial Performance
  • Table 101: Global Narcolepsy Market, Competitive Benchmarking (In USD Billions)
  • Table 102: Global Narcolepsy Market, Competitive Dashboard
  • Table 103: Global Narcolepsy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 104: Global, Narcolepsy Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 105: Global, Narcolepsy Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Table 106: Global, Narcolepsy Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030

List Of Figures

    Figure 1: Global Narcolepsy Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Narcolepsy Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Narcolepsy Market, Supply Chain Analysis
  • Figure 4: Global Narcolepsy Market, Major Raw Material Providers
  • Figure 5: Global Narcolepsy Market, Major Resource Providers
  • Figure 6: Global Narcolepsy Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Narcolepsy Market, Major Distributors And Channel Partners
  • Figure 8: Global Narcolepsy Market, Key Technologies & Future Trends
  • Figure 9: Global Narcolepsy Market, Major Trends
  • Figure 10: Global Narcolepsy Market, Major End Users
  • Figure 11: Global Narcolepsy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Narcolepsy Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Narcolepsy Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Narcolepsy Market - TAM, US$ Billion, 2025
  • Figure 15: Global Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Narcolepsy Market, Sub-Segmentation Of Type 1, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Narcolepsy Market, Sub-Segmentation Of Type 2, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Narcolepsy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Narcolepsy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Indonesia, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: South Korea, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Taiwan, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South East Asia, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Western Europe, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: UK, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Germany, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: France, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Italy, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Spain, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Eastern Europe, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Russia, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: North America, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: USA, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Canada, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: South America, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Brazil, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Middle East, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Africa, Narcolepsy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Narcolepsy Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Narcolepsy Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Global Narcolepsy Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 95: Global Narcolepsy Market - Company Scoring Matrix
  • Figure 96: Pfizer Inc. Financial Performance
  • Figure 97: Merck & Co. Inc Financial Performance
  • Figure 98: Novartis AG Financial Performance
  • Figure 99: Takeda Pharmaceutical Company Limited Financial Performance
  • Figure 100: Teva Pharmaceutical Industries Financial Performance
  • Figure 101: Global Narcolepsy Market, Competitive Benchmarking (In USD Billions)
  • Figure 102: Global Narcolepsy Market, Competitive Dashboard
  • Figure 103: Global Narcolepsy Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 104: Global, Narcolepsy Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 105: Global, Narcolepsy Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Figure 106: Global, Narcolepsy Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030

Frequently Asked Questions

The Narcolepsy market was valued at $3.95 billion in 2025, increased to $4.38 billion in 2026, and is projected to reach $6.62 billion by 2030.

The global Narcolepsy market is expected to grow at a CAGR of 10.9% from 2026 to 2035 to reach $6.62 billion by 2035.

Some Key Players in the Narcolepsy market Include, Pfizer Inc., Merck & Co. Inc, Novartis AG, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries, Otsuka Pharmaceutical, Sumitomo Pharma Company Limited, Jazz Pharmaceuticals, Alkermes

Major trend in this market includes: Development Of Extended-Release Medications In The Narcolepsy Market. For further insights on this market. request a sample here

North America was the largest region in the narcolepsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the narcolepsy market report are Asia-Pacific, South East Asia, W

Customer representative image Book your 30 minutes free consultation with our research experts